Hofseth BioCare ASA reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was NOK 30.22 million compared to NOK 16.73 million a year ago. Revenue was NOK 30.78 million compared to NOK 16.84 million a year ago. Net loss was NOK 35.67 million compared to NOK 26.84 million a year ago. Basic loss per share from continuing operations was NOK 0.1 compared to NOK 0.08 a year ago. Diluted loss per share from continuing operations was NOK 0.1 compared to NOK 0.08 a year ago.